Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity.

Sangani, Ruchika A; Lui, Justin K; Gillmeyer, Kari R; Trojanowski, Marcin A; Bujor, Andreea M; LaValley, Michael P; Klings, Elizabeth S

Sangani, Ruchika A; Lui, Justin K; Gillmeyer, Kari R; Trojanowski, Marcin A; Bujor, Andreea M; LaValley, Michael P; Klings, Elizabeth S.

Afiliación

Sangani RA; The Pulmonary Center Boston University School of Medicine Boston Massachusetts USA.
Lui JK; The Pulmonary Center Boston University School of Medicine Boston Massachusetts USA.
Gillmeyer KR; Department of Biostatistics Boston University School of Public Health Boston Massachusetts USA.
Trojanowski MA; The Pulmonary Center Boston University School of Medicine Boston Massachusetts USA.
Bujor AM; Arthritis and Autoimmune Diseases Center Boston University School of Medicine Boston Massachusetts USA.
LaValley MP; Arthritis and Autoimmune Diseases Center Boston University School of Medicine Boston Massachusetts USA.
Klings ES; Department of Biostatistics Boston University School of Public Health Boston Massachusetts USA.

Pulm Circ ; 12(4): e12117, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36238967

Palabras clave

pulmonary arterial hypertension; pulmonary fibrosis; scleroderma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pulm Circ Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google